2018 MIPS Measure #447: Chlamydia Screening and Follow Up

Measure Type High Priority Measure? NQS Domain
Process No Community/Population Health
Data Submission Method(s)
Registry

Measure Description

The percentage of female adolescents 16 years of age who had a chlamydia screening test with proper follow-up during the measurement period

Instructions

This measure is to be submitted once per performance period for patients seen during the performance period. This measure may be submitted by eligible clinicians who perform the quality actions described in the measure based on the services provided and the measure-specific denominator coding.

Measure Submission:

The listed denominator criteria is used to identify the intended patient population. The numerator options included in this specification are used to submit the quality actions allowed by the measure. The quality-data codes listed do not need to be submitted for registry submissions; however, these codes may be submitted for those registries that utilize claims data.

Denominator

Sexually active female adolescents who turned 16 years of age during the measurement period with a visit during the measurement period and a visit in the year prior to the measurement period

DENOMINATOR NOTE: Evidence of sexual activity includes any of the following:

  • Documentation of sexual activity
  • Prescription for contraception
  • Treatment or Screening for sexually transmitted disease – Pregnancy- Pelvic examination

*Signifies that this CPT Category I code is a non-covered service under the Medicare Part B Physician Fee Schedule (PFS). These non-covered services should be counted in the denominator population for registrybased measures.

Denominator Criteria (Eligible Cases):

Female Patients who turn 16 years of age during the measurement period

AND

Patient Encounter during the performance period (CPT): 99201, 99202, 99203, 99204, 99205, 99212, 99213, 99214, 99215, 99341, 99342, 99343, 99344, 99345, 99347, 99348, 99349, 99350, 99384, 99385, 99394, 99395 

AND

Patient Encounter during year prior to the performance period (CPT): 99201, 99202, 99203, 99204, 99205, 99212, 99213, 99214, 99215, 99341, 99342, 99343, 99344, 99345, 99347, 99348, 99349, 99350, 99384*, 99385*, 99394*, 99395* 

AND

Documentation of sexual activity: G9818

AND NOT

DENOMINATOR EXCLUSION:

Patients who use hospice services any time during the measurement period: G9819

Numerator

Adolescents who had documentation of a chlamydia screening test with proper follow-up during the measurement period 

Numerator Instructions: Documentation must include a note indicating the date and each of the following: A chlamydia test result AND for abnormal or indeterminate results, evidence of confirmatory testing, referral or treatment.

Numerator Options: 

Performance Met: 

Documentation of a chlamydia screening test with proper follow-up (G9820)

OR

Performance Not Met:

No documentation of a chlamydia screening test with proper follow-up (G9821)

Stay up to date with the latest news regarding MACRA and MIPS.

The Healthmonix Advisor is a free weekly news source, connecting you to the latest updates in the value-based care industry.